MKKGY
Price
$27.36
Change
+$0.13 (+0.48%)
Updated
Apr 2 closing price
Capitalization
76.59B
42 days until earnings call
SUPN
Price
$32.82
Change
+$1.14 (+3.60%)
Updated
Apr 2 closing price
Capitalization
1.84B
40 days until earnings call
Ad is loading...

MKKGY vs SUPN

Header iconMKKGY vs SUPN Comparison
Open Charts MKKGY vs SUPNBanner chart's image
Merck KGaA
Price$27.36
Change+$0.13 (+0.48%)
Volume$77.02K
Capitalization76.59B
Supernus Pharmaceuticals
Price$32.82
Change+$1.14 (+3.60%)
Volume$373.15K
Capitalization1.84B
MKKGY vs SUPN Comparison Chart
Loading...
MKKGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SUPN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MKKGY vs. SUPN commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MKKGY is a Hold and SUPN is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (MKKGY: $27.36 vs. SUPN: $32.82)
Brand notoriety: MKKGY and SUPN are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: MKKGY: 71% vs. SUPN: 59%
Market capitalization -- MKKGY: $76.59B vs. SUPN: $1.84B
MKKGY [@Pharmaceuticals: Other] is valued at $76.59B. SUPN’s [@Pharmaceuticals: Other] market capitalization is $1.84B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MKKGY’s FA Score shows that 1 FA rating(s) are green whileSUPN’s FA Score has 0 green FA rating(s).

  • MKKGY’s FA Score: 1 green, 4 red.
  • SUPN’s FA Score: 0 green, 5 red.
According to our system of comparison, both MKKGY and SUPN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MKKGY’s TA Score shows that 5 TA indicator(s) are bullish while SUPN’s TA Score has 4 bullish TA indicator(s).

  • MKKGY’s TA Score: 5 bullish, 5 bearish.
  • SUPN’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, SUPN is a better buy in the short-term than MKKGY.

Price Growth

MKKGY (@Pharmaceuticals: Other) experienced а +0.48% price change this week, while SUPN (@Pharmaceuticals: Other) price change was +1.52% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.40%. For the same industry, the average monthly price growth was +65.55%, and the average quarterly price growth was -10.24%.

Reported Earning Dates

MKKGY is expected to report earnings on May 15, 2025.

SUPN is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-2.40% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MKKGY($76.6B) has a higher market cap than SUPN($1.84B). SUPN has higher P/E ratio than MKKGY: SUPN (1677.00) vs MKKGY (21.41). MKKGY YTD gains are higher at: -4.436 vs. SUPN (-9.237). MKKGY has higher annual earnings (EBITDA): 6.45B vs. SUPN (90M). MKKGY has more cash in the bank: 1.72B vs. SUPN (255M). SUPN has less debt than MKKGY: SUPN (41.5M) vs MKKGY (10.6B). MKKGY has higher revenues than SUPN: MKKGY (22.3B) vs SUPN (608M).
MKKGYSUPNMKKGY / SUPN
Capitalization76.6B1.84B4,172%
EBITDA6.45B90M7,168%
Gain YTD-4.436-9.23748%
P/E Ratio21.411677.001%
Revenue22.3B608M3,668%
Total Cash1.72B255M675%
Total Debt10.6B41.5M25,542%
FUNDAMENTALS RATINGS
MKKGY vs SUPN: Fundamental Ratings
MKKGY
SUPN
OUTLOOK RATING
1..100
597
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
71
Overvalued
PROFIT vs RISK RATING
1..100
7540
SMR RATING
1..100
7078
PRICE GROWTH RATING
1..100
7572
P/E GROWTH RATING
1..100
70100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MKKGY's Valuation (28) in the null industry is somewhat better than the same rating for SUPN (71) in the Pharmaceuticals Other industry. This means that MKKGY’s stock grew somewhat faster than SUPN’s over the last 12 months.

SUPN's Profit vs Risk Rating (40) in the Pharmaceuticals Other industry is somewhat better than the same rating for MKKGY (75) in the null industry. This means that SUPN’s stock grew somewhat faster than MKKGY’s over the last 12 months.

MKKGY's SMR Rating (70) in the null industry is in the same range as SUPN (78) in the Pharmaceuticals Other industry. This means that MKKGY’s stock grew similarly to SUPN’s over the last 12 months.

SUPN's Price Growth Rating (72) in the Pharmaceuticals Other industry is in the same range as MKKGY (75) in the null industry. This means that SUPN’s stock grew similarly to MKKGY’s over the last 12 months.

MKKGY's P/E Growth Rating (70) in the null industry is in the same range as SUPN (100) in the Pharmaceuticals Other industry. This means that MKKGY’s stock grew similarly to SUPN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MKKGYSUPN
RSI
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
69%
Bearish Trend 1 day ago
66%
Momentum
ODDS (%)
Bearish Trend 1 day ago
51%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bearish Trend 1 day ago
52%
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
72%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
61%
Bullish Trend 1 day ago
71%
Advances
ODDS (%)
Bullish Trend 7 days ago
65%
Bullish Trend 10 days ago
74%
Declines
ODDS (%)
Bearish Trend 3 days ago
53%
Bearish Trend 22 days ago
66%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
79%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
54%
Bearish Trend 1 day ago
62%
View a ticker or compare two or three
Ad is loading...
MKKGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SUPN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CPCCX3.52N/A
N/A
Comstock Capital Value C
VYSEX14.02N/A
N/A
Voya Small Company R6
VVSGX14.85N/A
N/A
VALIC Company I Small Cap Growth
GLCCX18.35N/A
N/A
Goldman Sachs Large Cap Gr Insghts C
HAGIX70.47N/A
N/A
Carillon Eagle Mid Cap Growth I

MKKGY and

Correlation & Price change

A.I.dvisor indicates that over the last year, MKKGY has been loosely correlated with MKGAF. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MKKGY jumps, then MKGAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MKKGY
1D Price
Change %
MKKGY100%
+0.48%
MKGAF - MKKGY
49%
Loosely correlated
+1.67%
AMPH - MKKGY
25%
Poorly correlated
-1.73%
ZTS - MKKGY
25%
Poorly correlated
+0.98%
SUPN - MKKGY
25%
Poorly correlated
+3.60%
INDV - MKKGY
24%
Poorly correlated
+1.49%
More

SUPN and

Correlation & Price change

A.I.dvisor tells us that SUPN and DVAX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SUPN and DVAX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SUPN
1D Price
Change %
SUPN100%
+3.60%
DVAX - SUPN
30%
Poorly correlated
+1.26%
SNDL - SUPN
27%
Poorly correlated
N/A
ACET - SUPN
27%
Poorly correlated
-1.50%
ESPR - SUPN
26%
Poorly correlated
-1.42%
MKKGY - SUPN
24%
Poorly correlated
+0.48%
More